Wikidata

(Q46141389)

English

A phase II trial of human recombinant interleukin-2 administered as a 4-day continuous infusion for children with refractory neuroblastoma, non-Hodgkin's lymphoma, sarcoma, renal cell carcinoma, and malignant melanoma. A Childrens Cancer Group study

scientific article published in June 1995

In more languages

Statements

title
A phase II trial of human recombinant interleukin-2 administered as a 4-day continuous infusion for children with refractory neuroblastoma, non-Hodgkin's lymphoma, sarcoma, renal cell carcinoma, and malignant melanoma. A Childrens Cancer Group study (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7773948
retrieved
19 December 2017
reference URL
http://europepmc.org/abstract/MED/7773948

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q46141389&oldid=1871112841"